Hit evaluation of an α-helical peptide: Ala-scan, truncation and sidechain-to-sidechain macrocyclization of an RNA polymerase Inhibitor.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsKamal, Ahmed Ashraf Moustafa
Hartmann, Rolf Wolfgang
MetadataShow full item record
AbstractRNA polymerase (RNAP) remains a relatively underexplored target with only rifampicin and fidaxomicin in clinical use. Hence, the concurrent rise in bacterial resistance rate urges the search for novel RNAP inhibitors with novel mode of action. In this work, we investigated the impact of several systematic modifications including sidechain-to-sidechain macrocylization in α-helical content and biological activity of a previously identified inhibitory sigma factor fragment. Ala-scan results, peptide truncation from both the N- and C- terminus, and modifications inspired by other RNAP inhibitors revealed novel structure activity relationships but did not yield a superior sequence. Additionally, four insertion points for non-natural amino acids bearing side chains required for macrocylization were explored. Linear precursors showed improved stabilization of α-helical content compared to the original sequence as demonstrated by CD spectroscopy. However, this increase in α-helicity did not translate into improved biological activity. Instead, complete abolishment of RNAP inhibitory activity occurred. We hypothesize three possible reasons for such discrepancy and offer basis for further optimization efforts for this peptidic RNAP inhibitor.
CitationBiol Chem. 2019 Feb 25;400(3):333-342. doi: 10.1515/hsz-2018-0333.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
- Authors: Hinsberger S, Hüsecken K, Groh M, Negri M, Haupenthal J, Hartmann RW
- Issue date: 2013 Nov 14
- Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
- Authors: Sahner JH, Groh M, Negri M, Haupenthal J, Hartmann RW
- Issue date: 2013 Jul
- Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase.
- Authors: Xu W, Lau YH, Fischer G, Tan YS, Chattopadhyay A, de la Roche M, Hyvönen M, Verma C, Spring DR, Itzhaki LS
- Issue date: 2017 Feb 15
- Bacterial RNA polymerase inhibitors: an organized overview of their structure, derivatives, biological activity and current clinical development status.
- Authors: Mariani R, Maffioli SI
- Issue date: 2009
- Discovery and Structure-Based Optimization of 2-Ureidothiophene-3-carboxylic Acids as Dual Bacterial RNA Polymerase and Viral Reverse Transcriptase Inhibitors.
- Authors: Elgaher WA, Sharma KK, Haupenthal J, Saladini F, Pires M, Real E, Mély Y, Hartmann RW
- Issue date: 2016 Aug 11